Mirati Therapeutics | 销售和管理费用

Selling And Administration Expenses 更改 日
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Astellas Pharma JPY 179.28B 11.1B 2023-09
AstraZeneca USD 3.91B 194M 2023-09
Bayer EUR 3.6B 81M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Takeda JPY 252.95B 4.84B 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12



Mirati Therapeutics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.